Index -
P/E -
EPS (ttm) -381.56
Insider Own 7.28%
Shs Outstand 1.03M
Perf Week -9.91%
Market Cap 14.79M
Forward P/E -
EPS next Y -0.97
Insider Trans 0.00%
Shs Float 0.96M
Perf Month -11.90%
Income -31.54M
PEG -
EPS next Q -1.18
Inst Own 17.63%
Short Float 15.98%
Perf Quarter 223.42%
Sales 1.93M
P/S 7.66
EPS this Y 99.20%
Inst Trans -27.29%
Short Ratio 0.22
Perf Half Y -40.46%
Book/sh 9.11
P/B 1.58
EPS next Y -6.59%
ROA -116.06%
Short Interest 0.15M
Perf Year -97.99%
Cash/sh 7.20
P/C 1.99
EPS next 5Y -
ROE -524.01%
52W Range 3.95 - 1130.40
Perf YTD 57.80%
Dividend Est. -
P/FCF -
EPS past 5Y 49.49%
ROI -295.63%
52W High -98.73%
Beta 1.22
Dividend TTM -
Quick Ratio 1.82
Sales past 5Y 24.18%
Gross Margin 5.51%
52W Low 263.54%
ATR (14) 2.27
Dividend Ex-Date -
Current Ratio 1.82
EPS Y/Y TTM 64.11%
Oper. Margin -1229.30%
RSI (14) 53.02
Volatility 13.97% 15.02%
Employees 19
Debt/Eq 0.53
Sales Y/Y TTM -89.34%
Profit Margin -1638.65%
Recom 1.00
Target Price 35.00
Option/Short No / Yes
LT Debt/Eq 0.46
EPS Q/Q 95.92%
Payout -
Rel Volume 0.13
Prev Close 15.39
Sales Surprise 91.33%
EPS Surprise -110.42%
Sales Q/Q -36.27%
Earnings Mar 29 AMC
Avg Volume 681.87K
Price 14.36
SMA20 -2.62%
SMA50 43.14%
SMA200 -28.22%
Trades
Volume 91,654
Change -6.69%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-16-24 Upgrade
Oppenheimer
Perform → Outperform
$35
Sep-24-21 Initiated
RBC Capital Mkts
Outperform
$6
Apr-02-24 11:30AM
07:00AM
Mar-29-24 04:01PM
Mar-28-24 08:04AM
Mar-27-24 04:01PM
10:00AM
Loading…
10:00AM
Feb-26-24 11:28AM
Dec-27-23 07:00AM
Dec-07-23 07:00AM
Nov-09-23 07:00AM
Oct-31-23 07:00AM
Sep-27-23 08:00AM
Sep-26-23 07:00AM
Sep-12-23 07:00AM
Sep-06-23 07:00AM
07:00AM
Loading…
Aug-03-23 07:00AM
Jul-06-23 04:01PM
Jun-26-23 07:00AM
Jun-01-23 07:00AM
May-22-23 07:00AM
May-15-23 07:00AM
May-10-23 07:00AM
May-04-23 04:01PM
Mar-29-23 07:30AM
Mar-07-23 07:00AM
Feb-02-23 09:54PM
04:01PM
Jan-17-23 07:00AM
Nov-07-22 07:30AM
07:00AM
07:00AM
Loading…
Sep-06-22 07:00AM
Sep-01-22 07:00AM
Aug-11-22 04:01PM
Aug-09-22 10:39AM
Aug-04-22 07:30AM
Aug-02-22 07:30AM
Aug-01-22 07:00AM
Jul-06-22 04:05PM
Jun-20-22 12:10PM
Jun-02-22 07:30AM
May-18-22 07:30AM
May-17-22 07:30AM
May-05-22 07:30AM
Mar-08-22 07:00AM
Mar-02-22 07:30AM
Feb-17-22 07:30AM
Feb-07-22 04:01PM
Jan-10-22 07:59PM
Jan-06-22 07:30AM
Dec-16-21 07:30AM
Dec-06-21 07:30AM
Dec-05-21 06:43AM
Nov-11-21 07:00AM
Nov-09-21 04:01PM
Oct-13-21 07:00AM
Oct-06-21 04:15PM
Sep-20-21 07:00AM
Sep-17-21 09:11AM
Sep-14-21 10:23PM
04:01PM
Sep-06-21 06:43AM
Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
ARMISTICE CAPITAL, LLC 10% Owner Jun 27 '23 Sale 0.52 937,404 486,888 731,458 Jun 28 06:12 PM ARMISTICE CAPITAL, LLC 10% Owner Jun 26 '23 Sale 0.61 2,746,138 1,682,010 1,668,862 Jun 28 06:12 PM Caissa Capital Management ltd. 10% Owner Jun 20 '23 Buy 4.14 2,000 8,289 1,425,700 Jun 20 04:04 PM Caissa Capital Management ltd. 10% Owner Jun 16 '23 Buy 3.90 3,000 11,714 1,423,700 Jun 20 04:04 PM Caissa Capital Management ltd. 10% Owner Jun 15 '23 Buy 3.68 3,160 11,640 1,420,700 Jun 20 04:04 PM Caissa Capital Management ltd. 10% Owner Jun 14 '23 Buy 3.48 6,000 20,874 1,417,540 Jun 14 04:14 PM Caissa Capital Management ltd. 10% Owner Jun 13 '23 Buy 3.82 8,750 33,439 1,411,540 Jun 14 04:14 PM Caissa Capital Management ltd. 10% Owner Jun 12 '23 Buy 4.34 2,149 9,316 1,402,790 Jun 14 04:14 PM Caissa Capital Management ltd. 10% Owner Jun 09 '23 Buy 4.14 5,044 20,896 1,400,641 Jun 09 04:24 PM NEIL GARRY ARTHUR CEO and Chairman of the Board Jun 09 '23 Buy 3.42 4,000 13,680 13,220 Jun 13 04:39 PM Sullivan Christopher Ryan Chief Financial Officer Jun 09 '23 Buy 3.42 511 1,748 1,262 Jun 13 04:41 PM Caissa Capital Management ltd. 10% Owner Jun 08 '23 Buy 3.93 6,398 25,126 1,395,597 Jun 09 04:24 PM Caissa Capital Management ltd. 10% Owner Jun 07 '23 Buy 3.49 2,984 10,418 1,389,199 Jun 09 04:24 PM Caissa Capital Management ltd. 10% Owner May 31 '23 Buy 2.87 844 2,422 1,386,215 Jun 02 04:22 PM Caissa Capital Management ltd. 10% Owner May 30 '23 Buy 2.87 671 1,924 1,385,371 May 30 04:27 PM Caissa Capital Management ltd. 10% Owner May 25 '23 Buy 2.77 2,000 5,540 1,384,700 May 30 04:27 PM Caissa Capital Management ltd. 10% Owner May 24 '23 Buy 2.98 9,000 26,816 1,382,700 May 24 04:15 PM Caissa Capital Management ltd. 10% Owner May 22 '23 Buy 3.34 7,000 23,358 1,373,700 May 22 04:30 PM Caissa Capital Management ltd. 10% Owner May 19 '23 Buy 3.52 6,500 22,852 1,366,700 May 22 04:30 PM Caissa Capital Management ltd. 10% Owner May 18 '23 Buy 3.29 13,121 43,163 1,360,200 May 22 04:30 PM Caissa Capital Management ltd. 10% Owner May 16 '23 Buy 2.75 379 1,042 1,347,079 May 16 05:23 PM Caissa Capital Management ltd. 10% Owner May 15 '23 Buy 2.55 1,715 4,366 1,346,700 May 16 05:23 PM Caissa Capital Management ltd. 10% Owner May 12 '23 Buy 2.45 2,285 5,598 1,344,985 May 16 05:23 PM Caissa Capital Management ltd. 10% Owner May 08 '23 Buy 2.62 5,000 13,108 1,342,700 May 08 04:10 PM Caissa Capital Management ltd. 10% Owner May 05 '23 Buy 2.88 5,000 14,375 1,337,700 May 08 04:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite